Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TPST Tempest Therapeutics Inc.

Market Closed 11-06 16:00:00 EST

0.3806

+0.0054

+1.44%

盘后0.3806

+0.00000.00%

19:47 EST

High0.4100	Low0.3800	Vol86.10K
Open0.4100	D1 Closing0.3752	Amplitude8.00%
Mkt Cap7.61M	Tradable Cap5.68M	Total Shares20.00M
T/O33.68K	T/O Rate0.58%	Tradable Shares14.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":0.3806,"timestamp":1793998800000,"preClose":0.3752,"halted":0,"volume":86100,"hourTrading":{"tag":"盘后","latestPrice":0.3806,"preClose":0.3806,"latestTime":"19:47 EST","volume":8718,"amount":3262.4087,"timestamp":1794012476589,"change":0,"changeRate":0,"amplitude":0.032055},"delay":0,"changeRate":0.014392324093816675,"floatShares":14920600,"shares":19995400,"eps":-4.561698,"marketStatus":"Market Closed","change":0.0054,"latestTime":"11-06 16:00:00 EST","open":0.41,"high":0.41,"low":0.38,"amount":33679.646595,"amplitude":0.079957,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-4.561698,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3752,"preHourTrading":{"tag":"盘前","latestPrice":0.42,"preClose":0.3752,"latestTime":"09:08 EST","volume":3079,"amount":1197.1139684,"timestamp":1793974080768,"change":0.0448,"changeRate":0.119403,"amplitude":0.11887},"postHourTrading":{"tag":"盘后","latestPrice":0.3806,"preClose":0.3806,"latestTime":"19:47 EST","volume":8718,"amount":3262.4087,"timestamp":1794012476589,"change":0,"changeRate":0,"amplitude":0.032055},"volumeRatio":0.48364863163377225,"impliedVol":1.4125,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TPST/tweets","defaultTab":"tweets","newsList":[{"id":"2681485068","title":"Tempest Therapeutics Receives NASDAQ Notice over Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2681485068","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681485068?lang=en_us&edition=fundamental","pubTime":"2026-11-06 19:03","pubTimestamp":1793963034,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Receives Nasdaq Notice Over Minimum Bid Price DeficiencyTempest Therapeutics received a Nasdaq noncompliance notice November 4, 2026, following 30 consecutive business days with i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nNDL1z0r0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680764557","title":"Tempest Therapeutics Files Initial Beneficial Ownership Statement for CFO, Treasurer and Corporate Secretary Stephanie Horn-Warnock","url":"https://stock-news.laohu8.com/highlight/detail?id=2680764557","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680764557?lang=en_us&edition=fundamental","pubTime":"2026-11-04 02:01","pubTimestamp":1793728870,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Files Initial Beneficial Ownership Statement for CFO, Treasurer and Corporate Secretary Stephanie Horn-WarnockTempest Therapeutics CFO, treasurer and corporate secretary Stephanie","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL93RTNm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679247974","title":"Tempest Therapeutics Names Stephanie Horn-Warnock CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2679247974","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679247974?lang=en_us&edition=fundamental","pubTime":"2026-10-31 04:06","pubTimestamp":1793390785,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Names Stephanie Horn-Warnock CFOTempest Therapeutics appointed Stephanie Horn-Warnock chief financial officer effective immediately on October 26, 2026.She succeeds Constance Ames","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nNDL1Jbfxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679921247","title":"Tempest Therapeutics - Appoints Stephanie Horn-Warnock as CFO, Treasurer, Corporate Secretary Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2679921247","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679921247?lang=en_us&edition=fundamental","pubTime":"2026-10-31 04:06","pubTimestamp":1793390769,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nFWN46G3SS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679247925","title":"Tempest Therapeutics - Constance Ames Resigns as Chief Financial Officer Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2679247925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679247925?lang=en_us&edition=fundamental","pubTime":"2026-10-31 04:06","pubTimestamp":1793390769,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nFWN46G3SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677961676","title":"Tempest Therapeutics Holds Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2677961676","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677961676?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:12","pubTimestamp":1792527140,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Holds Special Stockholder MeetingTempest Therapeutics adjourned its October 14, 2026, special stockholder meeting because a proposed charter amendment lacked sufficient votes for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL89tzY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676368116","title":"Tempest Therapeutics Appoints John W. Frederick to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2676368116","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676368116?lang=en_us&edition=fundamental","pubTime":"2026-10-20 04:22","pubTimestamp":1792441333,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Appoints John W. Frederick to Board of DirectorsTempest Therapeutics appointed John W. Frederick to its board of directors today.Frederick most recently served as Skillsoft's chie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDL1V78gC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKIL","TPST","BK4139","BK4130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675388341","title":"Tempest Therapeutics Appoints John W. Frederick to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675388341","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675388341?lang=en_us&edition=fundamental","pubTime":"2026-10-14 20:02","pubTimestamp":1791979373,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics appoints John W. Frederick to board of directorsTempest Therapeutics named John W. Frederick to its board of directors.Frederick most recently served as CFO of Skillsoft, overseei","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nNDL4MZH0W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014021.USD","BK4130","SG9999014039.USD","NDAQ","BK4588","IE00BQXX3D17.EUR","LU0314104364.USD","SKIL","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BCDF","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","TPST","LU2210150020.SGD","BK4139","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675349099","title":"Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise","url":"https://stock-news.laohu8.com/highlight/detail?id=2675349099","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675349099?lang=en_us&edition=fundamental","pubTime":"2026-10-14 20:00","pubTimestamp":1791979204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA2SJJK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673060218","title":"Sensorion Names Louis J. Arcudi III CFO, Replacing Laurene Danon","url":"https://stock-news.laohu8.com/highlight/detail?id=2673060218","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673060218?lang=en_us&edition=fundamental","pubTime":"2026-10-07 13:30","pubTimestamp":1791351021,"startTime":"0","endTime":"0","summary":"Sensorion names Louis J. Arcudi III CFO, replacing Laurene DanonSensorion named Louis J. Arcudi III chief financial officer effective Oct. 7, 2026, based in the Boston area.Arcudi was CFO of Amolyt Ph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL6yGKDH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0526926950.USD","LU2125909593.SGD","TPST","LU2355687059.USD","LU0171293334.USD","LU0310799852.SGD","AZN.UK","LU2112291526.USD","LU0496365809.HKD","LU0345777147.USD","LU1003076772.USD","LU1880407215.USD","LU0949170426.SGD","SG9999001176.USD","LU0889565080.SGD","LU0211326755.USD","LU0158827948.USD","LU1019632923.USD","LU1267930813.SGD","LU0047473722.EUR","LU0857590862.USD","LU0553294199.USD","LU0128525929.USD","IE00B3T34201.USD","LU1481600234.SGD","LU0920783379.SGD","LU0661504455.SGD","IE00B2B36J28.USD","LU0792757196.USD","LU1046234339.USD","LU1481599808.USD","LU1487256676.USD","LU0976567544.SGD","LU0823399737.USD","LU1355424745.HKD","LU1051770623.HKD","LU0963555726.SGD","LU1496350171.SGD","IE00BFTCPJ56.SGD","IE00BKPKM643.USD","LU1267930227.SGD","LU0128525689.USD","LU0266013472.USD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0171276677.USD","LU2279689827.SGD","LU0957799991.USD","03165","LU1301847155.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672493557","title":"Tempest Therapeutics Names Nancy Freda-Smith to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2672493557","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672493557?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:18","pubTimestamp":1790972325,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics names Nancy Freda-Smith to boardTempest Therapeutics named Nancy Freda Smith as a director, effective Sept. 22, 2026.Disclaimer:This news brief was created by Public Technologies ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6DHMf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671572812","title":"Tempest Therapeutics Appoints Nancy Freda-Smith to Board, Names Her Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2671572812","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671572812?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:06","pubTimestamp":1790625993,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chairTempest Therapeutics appointed Nancy Freda-Smith to its board of directors.Freda-Smith will serve as chair of t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL6PWxvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670424113","title":"Tempest Therapeutics - Prospectus Filed for Offer and Resale of up to 9,534,164 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670424113","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670424113?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:31","pubTimestamp":1790368270,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H0LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914614","title":"Tempest Therapeutics Inc : H.c. Wainwright Cuts Target Price to $7 from $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669914614?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:18","pubTimestamp":1790263113,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G12Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483478","title":"Tempest Therapeutics Appoints Nancy Freda-Smith to Board, Names Her Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483478","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483478?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:04","pubTimestamp":1790165045,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chairTempest Therapeutics appointed Nancy Freda-Smith to its board of directors.Freda-Smith will serve as chair of t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL7YSwK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","TPST","IE00B3QW5Z07.USD","LU0006061336.USD","IE00BN0W2T93.GBP","RL","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2095319765.USD","SG9999014005.SGD","BK4585","BK4588","BK4112","IE00BQXX3C00.GBP","SG9999014013.SGD","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","BK4139","BK4202","SG9999014021.USD","LU0963586101.USD","IE00BN0W2V16.EUR","BCDF","IE00BQXX3D17.EUR","LU0314104364.USD","STYL","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0054578231.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669978483","title":"Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669978483","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669978483?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:00","pubTimestamp":1790164801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA9NVFL4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668299752","title":"Tempest Therapeutics Signs Exclusive Option Deal with Senlang for CD7-Targeted in Vivo CAR-T Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2668299752","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668299752?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:06","pubTimestamp":1789679175,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics signs exclusive option deal with Senlang for CD7-targeted in vivo CAR-T platformTempest Therapeutics entered an exclusive option agreement with Hebei Senlang Biotechnology to lice","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLmQCqz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668686935","title":"Tempest Therapeutics Special Meeting Adjourned After Proposal Fell Short of 75% Vote Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2668686935","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668686935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:38","pubTimestamp":1789591092,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics special meeting adjourned after proposal fell short of 75% vote thresholdTempest Therapeutics held a reconvened special shareholder meeting on Sept. 15, 2026 to vote on a charter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL8Cnm5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667335600","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667335600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667335600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:12","pubTimestamp":1789557137,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics  stock was 45% higher in Wednesday's premarket activity, a day after the company said it signed an exclusive option agreement with China's Hebei Senlang Biotechnology.ReTo Eco-Solutions  shares were up over 41% following a more than 676% rise in the prior session.YYForce  stock was 23% higher after the company reported its estimated total and net assets.Future FinTech Group  shares were up 12%, swinging from a 29% fall at Tuesday's close.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TPST","BK4011","RETO","FTFT","BK4120","BK4122","YFOR","BK4164","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667627808","title":"Tempest Therapeutics Gains Option to License New In-Body CAR-T Technology From Senlang","url":"https://stock-news.laohu8.com/highlight/detail?id=2667627808","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667627808?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:45","pubTimestamp":1789508730,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics  signed an exclusive option agreement with China's Hebei Senlang Biotechnology to license a clinical-stage technology that delivers CAR-T cancer treatments directly inside the body, along with a portfolio of related drug candidates.The portfolio includes an early-stage treatment that targets two proteins linked to multiple myeloma and is now being tested in a phase 1 study, Tempest said Tuesday in a statement. Other candidates in the group are aimed at blood cancers and autoimmune diseases, the company said.Tempest said it will continue to evaluate phase 1 results with Senlang during the option period.The company also disclosed in a regulatory filing that it raised about $2.5 million last week through a private placement of prefunded and common stock warrants.Tempest shares rose 35% in after-hours trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4539","TPST","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":-0.2319},{"period":"1month","weight":-0.5191},{"period":"3month","weight":-0.5848},{"period":"6month","weight":-0.8087},{"period":"1year","weight":-0.9601},{"period":"ytd","weight":-0.8674}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.012727},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.032927},{"month":3,"riseRate":0.461538,"avgChangeRate":0.000618},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.113004},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011916},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.124765},{"month":7,"riseRate":0.214286,"avgChangeRate":-0.03977},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.030843},{"month":9,"riseRate":0.5,"avgChangeRate":-0.071754},{"month":10,"riseRate":0.428571,"avgChangeRate":0.849395},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.092171},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.062561}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tempest Therapeutics Inc.(TPST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tempest Therapeutics Inc.(TPST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}